Press Release

Global Recombinant Proteins Market to Record a Substantial CAGR of Around 7.4% During 2024-30

The Global Recombinant Proteins Market is anticipated to grow at a CAGR of about 7.4% during the forecast period of 2024-30, cites MarkNtel Advisors in the recent research report. The rise in conditions such as cerebral apoplexy, multiple sclerosis, neutropenia, and thrombocytopenia has spurred demand for recombinant protein drugs. Simultaneously, treatment modalities like cancer therapy, mammalian cell culture, and recombinant protein western blotting are experiencing increased usage, bolstering market growth globally. Owing to their pivotal role in advancing therapeutic solutions, recombinant proteins have attracted substantial investments in research and development from healthcare providers and pharmaceutical firms. This investment surge is poised to unlock abundant opportunities for market growth & expansion across regions worldwide.

Further, diagnostics and disease monitoring represent a burgeoning opportunity in the recombinant proteins market. Engineered through innovative biotechnological approaches, these proteins offer precise detection of biomarkers and pathogens linked to various diseases. Their sensitivity and specificity make them invaluable for early disease detection, surveillance, and monitoring, promising improved patient outcomes. Hence, the pharma & bio-pharma companies are extensively utilizing various recombinant products to develop highly effective diagnostic solutions based on these proteins. By utilizing these products for diagnostic & Clinical investigation purposes, the organizations would achieve improved healthcare delivery that would contribute to more effective disease management strategies. Consequently, this would help the organizations to address the unmet medical needs and propel growth in the Global Recombinant Proteins Market.

Additionally, the health issues in the developing economies are intensifying. As a result, the academic institutions & research centers in these countries are aligning their efforts to develop highly advanced therapeutic drugs for chronic illnesses. Along with it, the increasing incidences of rare genetic disorders are affecting millions of individuals worldwide, underscoring the urgent need for breakthrough treatments and improved healthcare infrastructure. Therefore, market players are making substantial investments in their R&D, contributing significantly to innovation in the biopharmaceutical sector. This continuous evolution in the pharmaceutical sector would continue to positively contribute to amplifying the demand for recombinant proteins, further states the research report, “Global Recombinant Proteins Market Analysis, 2024.”

Global Recombinant Proteins Market Segmentation Analysis

The Growth Factors & Cytokines Segment Holds a Major Market Share

Based on the product, the market is further bifurcated into Growth Factors and Cytokines, Antibodies, Immune Checkpoint Proteins, Structural Proteins, Enzymes, Recombinant Regulatory Proteins, Hormones, and Others (Membrane Proteins, Adhesion Molecules & Receptors, etc.). Of them all, the growth factor and cytokines hold a dominant market share in the Global Recombinant Proteins Market. These products are highly used for developing drugs that help in recovering from stitches, wounds & tissue injury. Therefore, the rising occurrences of surgeries across the globe are enhancing the requirement for growth factors & cytokines. Moreover, the elderly population across the globe are dealing with joint and ligament issues & other orthopedic problems. As a result, these individuals are undergoing orthopedic surgeries. This is consequently, uplifting the demand for the growth factors & cytokines to ensure speedy recovery of the individuals. Additionally, the younger demographics are increasingly becoming conscious of their looks. Owing to this, they are taking specific facial treatments & going through facial surgeries. This surge in cosmetics procedures would continue to uplift the demand for the growth factors & cytokines in the forecast period as well.    

North America Dominates the Global Recombinant Proteins Market

Geographically, North America holds a noteworthy market share in the Global Recombinant Proteins Market. The nations in the North American region have highly advanced healthcare infrastructure, comprising the healthcare facilities for incurable diseases as well. These healthcare facilities offer therapeutic treatments to their inhabitants. As a result, the demand for therapeutic drugs in these nations is increasing. Therefore, to cater to this growing need, the bio-pharma & pharma companies are increasingly developing therapeutic drugs using recombinant proteins, elevating market growth. Additionally, the research organizations within the North American region are investing their resources to develop highly advanced therapies to strengthen their pharmaceutical sector. Consequently, this development & clinical investigation to produce highly effective drugs to cure chronic illnesses is further enlarging the market size.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abcam Limited, Novozymes A/S, GenScript Biotech Corporation, R&D Systems, Inc., ProSpec-Tany TechnoGene Ltd., Cell Signaling Technology, Inc., Enzo Life Sciences, Inc., Sino Biological Inc., Miltenyi Biotec, Abnova Corporation, RayBiotech, Inc., OriGene Technologies, Inc., and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Market Size- By Value, Forecast Numbers, Segmentation, Market Shares)?
2. What are the market trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across the regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?